Discover hundreds of clinical trials in Utah.
Search clinical trials in Utah by city, condition or phase.
Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.
Utah offers distinct advantages for those participating in clinical trials. The state's diverse population, combined with its strong emphasis on community health and wellness, enriches the research landscape with a wide range of participants. Utah is also recognized for its innovative research environment, with a notable focus on advancing medical science and exploring cutting-edge treatments, particularly in pediatrics.
Choosing to participate in a clinical trial in Utah means contributing to crucial medical research while benefiting from a supportive and well-established clinical research system. Utah’s commitment to excellence in research, along with its collaborative approach and advanced facilities, makes it an excellent choice for those looking to engage in meaningful and impactful studies.
With leading healthcare institutions and strong research infrastructure, clinical research in Utah covers a wide range of medical conditions.
With a high prevalence of heart disease in the state, Utah is a hub for cardiovascular disease research. Cardiovascular disease clinical trials in Utah seek to investigate a range of innovative treatments and interventions aimed at improving heart health and managing cardiovascular conditions.
Current trials include research on new medications for managing heart failure and hypertension, as well as advanced stent technologies and drug-eluting devices for coronary artery disease. Studies are also exploring novel therapies for atrial fibrillation, including new anticoagulants and catheter-based ablation techniques, in addition to regenerative medicine approaches like stem cell therapies.
In Utah, clinical trials for neurological disorders have become a key focus as the state sees increasing numbers of citizens living with neurodegenerative diseases such as Alzheimer’s disease. Trials here explore a range of innovative treatments and approaches designed to address various conditions affecting the nervous system.
Current trials include research on novel drug therapies for Alzheimer’s disease, focusing on disease-modifying treatments and cognitive enhancers. For Parkinson’s disease, studies are investigating new medications, gene therapies, and deep brain stimulation techniques to manage symptoms and potentially slow disease progression. Trials are also underway for multiple sclerosis (MS), evaluating new disease-modifying therapies and advanced imaging techniques to monitor disease activity and treatment response.
Cancer clinical trials in Utah are actively exploring a variety of innovative treatments and therapeutic approaches aimed at improving patient outcomes. These clinical trials are particularly crucial in the state due to its high incidence of certain cancer types, for example, melanoma, and the growing need for advanced treatment options.
Current trials include studies on advanced immunotherapies, such as CAR-T cell therapy and checkpoint inhibitors, as well as new targeted therapies that focus on specific genetic mutations within tumors, offering more personalized treatment options for cancers like breast, lung, and prostate. Research is also being conducted on novel combinations of existing therapies, as well as new drug delivery systems and early detection methods.
With an increase in diabetes rates across the state, clinical research teams are placing an emphasis on investigating all types of the condition. Clinical trials for diabetes in Utah are actively investigating a variety of innovative treatments and management strategies aimed at improving outcomes for individuals with diabetes.
Current research includes trials on novel insulin formulations and delivery systems, such as advanced insulin pumps and continuous glucose monitoring systems, new pharmacological treatments for Type 1 and Type 2 diabetes, and emerging technologies like closed-loop insulin delivery systems and potential regenerative therapies.
Utah is a prime destination for autoimmune disease clinical research due to its leading institutions, including the University of Utah Health and Intermountain Healthcare. These centers are renowned for their state-of-the-art research facilities and expertise in autoimmune diseases.
Clinical trials for autoimmune diseases seek to develop new treatments and therapies for a range of conditions, including rheumatoid arthritis, lupus, and multiple sclerosis (MS). Current research includes trials on novel biologics and small molecule drugs that target specific immune system pathways involved in these diseases, as well as immunosuppressive agents, disease-modifying drugs, and stem cell treatments.
Mental health conditions are often researched in Utah, primarily due to the nation and state’s increasing awareness and emphasis on mental health issues. Clinical trials for mental health conditions investigate a variety of innovative treatments and therapeutic approaches to address several common and complex disorders.
Current research includes trials on new antidepressants and anxiolytics for conditions such as depression and generalized anxiety disorder. Studies are also exploring the potential of psychedelic therapies, like psilocybin and ketamine, for treatment-resistant depression and PTSD.
Clinical trials in the state are also focusing on advanced psychotherapies, including digital mental health interventions and novel cognitive-behavioral therapies, to enhance accessibility and efficacy in treating mental health disorders.
Clinical trials are governed by a combination of federal, state, and institutional regulations in Utah to ensure participant safety and ethical conduct. At a federal level, the FDA oversees the approval process for investigational drugs and devices, while Institutional Review Boards (IRBs) at research institutions ensure each trial meets ethical standards and safeguards participant wellbeing. Informed consent is a key requirement, ensuring participants fully understand the risks and benefits before agreeing to participate.
The Utah Department of Health provides additional oversight, particularly in protecting vulnerable populations such as minors and the elderly. Institutions like the University of Utah Health and Intermountain Healthcare follow strict protocols related to patient care, data management, and privacy protection, adhering to HIPAA standards to secure participant data.
Participating in a clinical trial offers several benefits, including early access to new treatments and therapies that have not yet reached the general public. Throughout the process, participants receive dedicated care from top healthcare professionals, who provide thorough monitoring and specialized support during the study.
Additionally, involvement in clinical trials plays a crucial role in advancing medical research, potentially leading to significant breakthroughs in treatment. By joining a trial, individuals not only access innovative medical options but also contribute to the progress of science, helping to enhance future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
University of Utah
Location:
Code:
NCT06108089
Conditions
Head and Neck Cancer
Hypoxia
Magnetic Resonance Imaging
Cancer Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
[18F]MISO-PET/CT
Sponsor:
Shriners Hospitals for Children
Location:
Code:
NCT06305689
Conditions
Idiopathic Toe Walking
Eligibility Criteria
Sex: All
Age: 6 - 18
Healthy Volunteers: Not accepted
Interventions
Surgery
Serial Casting
Sponsor:
Incyte Corporation
Location:
Code:
NCT05696392
Conditions
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ruxolitinib cream
Sponsor:
Hummingbird Diagnostics
Location:
Code:
NCT05987189
Conditions
Lung Cancer
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
miLungDx
Sponsor:
AMO Pharma Limited
Location:
Code:
NCT05004129
Conditions
Congenital Myotonic Dystrophy
Eligibility Criteria
Sex: All
Age: 6 - 45
Healthy Volunteers: Not accepted
Interventions
Tideglusib
Sponsor:
Philogen S.p.A.
Location:
Code:
NCT03567889
Conditions
Melanoma Stage IIIB/C
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daromun
Surgery
Adjuvant therapy
Sponsor:
University of Utah
Location:
Code:
NCT05433389
Conditions
Pain
Anxiety State
Depressive State
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Breath Counting
Body Scan
Mindful Breathing
Mindfulness of Pain
Mindful Savoring
Sponsor:
Verastem, Inc.
Location:
Code:
NCT05669482
Conditions
KRAS Activating Mutation
Metastatic Cancer
Pancreas Cancer
Neoplasms Pancreatic
Malignant Neoplasm of Pancreas
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel